Six researchers from MD Anderson elected as AAAS Fellows
In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been...
In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been...
Researchers at Cardiff University have found a way to boost the cancer-destroying ability of the immune system's T-cells, offering new hope in the fight against...
The issue was guest edited by Ron Allison (The Brody School of Medicine, USA) who stated: "Imagine a tumor lighting up for the surgeon to...
The Prostate Health Index (phi) is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts...
LUGANO, 20 November 2017 - A randomised trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic...
LUGANO, 20 November 2017 - Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according...
Credit: CeMM/ Abdelghani Mazouzi (Vienna, Nov. 17, 2017) The destructive force of UV radiation on DNA molecules is only fully visible, when repair mechanisms fail:...
Credit: © European Society for Medical Oncology LUGANO, Switzerland - The European Society for Medical Oncology (ESMO) opened its 3rd ESMO Asia Congress today, once...
CHICAGO - Women with higher body mass index (BMI) face an increased risk of not detecting their breast tumor until it has become large, according...
CAMBRIDGE, MA - Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by...
WASHINGTON -- Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators....
A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Nov. 20, 2017) - A national cooperative group trial is making a handful of the country's...
ANN ARBOR, Michigan -- The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop....
A subanalysis of the phase III ALEX study has shown that alectinib (1) 600 mg twice daily is more effective than standard of care crizotinib...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.